JATT II Acquisition Corp
Key Metrics
- Previous Close
- $13.18
- 52-Week Range
- $9.99 – $23.76
- Market Cap
- $101.48M
- P/E (TTM)
- —
- EPS (TTM)
- —
- Dividend Yield
- —
Advanced Metrics
- Price/Book
- —
- PEG Ratio
- —
- Return on Equity
- —
- Return on Assets
- —
- Gross Margin
- 0.00%
- Operating Margin
- 0.00%
- Profit Margin
- 0.00%
- Current Ratio
- —
- Debt/Equity
- —
- Total Debt
- $0.00
- Free Cash Flow
- —
- Revenue Growth
- —
- Earnings Growth
- —
- Enterprise Value
- $99.84M
Market Snapshot
About
JATT II Acquisition Corp (JATT) is a special purpose acquisition company, also known as a SPAC, incorporated in 2026 and based in Westfield, New Jersey. It was formed for the purpose of merging with or acquiring an operating business.
As a blank-check company, JATT II has no commercial operations of its own. It raised capital through an initial public offering, with those proceeds held in a trust. The company’s stated objective is to identify and complete a business combination with one or more companies operating within the healthcare sector. This target may include businesses providing healthcare services, medical technology, pharmaceuticals, or other related fields.
No business combination has been completed as of the latest available information. The company’s management team is tasked with evaluating potential acquisition targets. The ultimate goal of this structure is to provide a private company a path to becoming a publicly traded entity via the merger with the SPAC, rather than through a traditional IPO process.